Pradama Inc. is a pharmaceutical company that creates multiple products for bone diseases and disorders using its novel bone-targeting drug delivery technology. Bone tissue is distinguished from other tissues by the presence of bone mineral, mainly hydroxyapatite. Pradama's bone-targeting agents have significant affinity for hydroxyapatite. Pradama’s bone-targeting agents have several advantages over other bone-targeting approaches, including; oral availability, therapeutic inactivity, stability and flexibility.
The winners will be announced at an awards ceremony on Tuesday, January 26 at the Drug Delivery Partnerships International Conference.
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment